Recurrence of Hepatitis B is Associated with Cumulative Corticosteroid Dose and Chemotherapy Against Hepatocellular Carcinoma Recurrence After Liver Transplantation
Open Access
- 22 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 13 (3) , 451-458
Abstract
The incidence of hepatitis B (HB) recurrence after a liver transplantation has been reduced by prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine. However, the long-term incidence of recurrence is P = 0.015). However, the incidence of HB recurrence was similar in the HBIG (6.3%) and combination group (13.8%), as well as between the active replicators (12.5%) and nonreplicators (4.1%) (P < 0.05). There was a far higher incidence of HB recurrence in patients receiving corticosteroid pulse therapy (21.0% vs. 7.9%), patients who experienced HCC recurrence (31.3% vs. 8.6%), and patients receiving chemotherapy to prevent HCC recurrence (25.0% vs. 4.4%) (P < 0.05). The cumulative corticosteroid dose was higher in patients who experienced recurrence of HB (P = 0.002). Multivariable analysis confirmed the effect of the cumulative corticosteroid dose and chemotherapy to be risk factors. Liver transplantation for HB is safe, with low recurrence rates if adequate prophylaxis is used. However, the cumulative corticosteroid dose and the chemotherapy used for HCC were risk factors for HB recurrence, so careful monitoring for HB recurrence is needed in these patients. Liver Transpl 13:451–458, 2007. © 2007 AASLD.Keywords
This publication has 26 references indexed in Scilit:
- Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesAnnals of Clinical Microbiology and Antimicrobials, 2006
- Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspectiveLiver Transplantation, 2005
- Viral load at the time of liver transplantation and risk of hepatitis B virus recurrenceLiver Transplantation, 2005
- Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis BTransplant International, 2004
- Evolving strategies to prevent HBV recurrenceLiver Transplantation, 2004
- Outcome of liver transplantation for hepatitis B in the United StatesLiver Transplantation, 2004
- Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive ImmunoprophylaxisHepatology, 2003
- Prevention of recurrent hepatitis B post-liver transplantationLiver Transplantation, 2002
- Banff Schema for Grading Liver Allograft Rejection: An International Consensus DocumentHepatology, 1997
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993